(Charlottetown, PE, January 26, 2018) Neurodyn Cognition Inc. (‘Neurodyn’ or the ‘Company’) today announced that its’ CEO, Mr. Kenneth Cawkell will be a featured presenter at NobleCon14, Noble Capital Markets’ Fourteenth Annual Investor Conference in Fort Lauderdale, Florida on January 30. Cawkell will give an overview of the company’s clinical-stage Alzheimer’s disease drug candidate, Memogain, which is an improved reformulation of an established class of Alzheimer’s drugs. Memogain has successfully completed two Phase I Trials demonstrating a dramatically wider therapeutic window, a well established clinical pathway and potential for accelerated approval.
“We look forward to showcasing to investors our response to a growing need for a near term solution for Alzheimer’s Disease,” says Cawkell. “The potential market is massive and the demand unprecedented.”
Neurodyn’s Chief Scientific Officer, Dr. Denis Kay, will also be attendance.
The presentation may be viewed [here].
About Neurodyn Cognition
Neurodyn Cognition Inc. ( http://www.neurodyncognition.ca )is a private Canadian biotech company developing Memogain, a patented prodrug of an approved treatment for Alzheimer’s disease, galantamine (Reminyl®). Memogain’s intranasal administration achieves higher dose levels, with significantly greater brain bioavailability, while avoiding the compliance impairing gastro-intestinal adverse effects of existing symptomatic treatments. In addition to improved cognition the increased brain concentrations enhances the drugs unique and safe mechanism of sensitization of neuronal nicotinic acetylcholine receptors, most notably the alpha-7 subtype, which could result in the potential for disease modifying neuroprotective effects.
About Noble Capital Markets, Inc.
Noble Capital Markets, ( www.noblecapitalmarkets.com ) established in 1984, is an equity-research-driven, full-service, investment & merchant banking boutique focused on the healthcare, media & entertainment, technology, transportation & logistics and natural resources sectors. The company has offices in Boca Raton, New York, Boston and St. Louis. In addition to NobleCon – the annual multi-sector investor conference – and the Media, Finance & Investor Program, produced in partnership with the National Association of Broadcasters (NAB) and held each spring in Las Vegas, throughout the year Noble hosts numerous “non-deal” corporate road shows across the United States and Canada. Members: FINRA, SIPC, MSRB.
For more information, please contact:
Mr. Kenneth Cawkell, Chief Executive Officer
firstname.lastname@example.org | 1.604.619.0990
Dr. Denis Kay, Chief Scientific Officer
email@example.com | 1.902.314.0776